Correlation between dual-time-point FDG PET and tumor microenvironment immune types in non-small cell lung cancer (NSCLC)
J Zhou, S Zou, S Cheng, D Kuang, D Li, L Chen, C Liu… - 2020 - Soc Nuclear Med
299 Purpose: Dual-time-point (DTP) 18 F-FDG PET, which reflects the dynamics of tumor
glucose metabolism, may provide a way to characterize tumor and immune cells within …
glucose metabolism, may provide a way to characterize tumor and immune cells within …
[HTML][HTML] Correlation between dual-time-point FDG PET and tumor microenvironment immune types in non-small cell lung cancer
J Zhou, S Zou, S Cheng, D Kuang, D Li, L Chen… - Frontiers in …, 2021 - frontiersin.org
Purpose Dual-time-point 18F-fluorodeoxyglucose positron emission tomography (DTP 18F-
FDG PET), which reflects the dynamics of tumor glucose metabolism, may also provide a …
FDG PET), which reflects the dynamics of tumor glucose metabolism, may also provide a …
Correlation between metabolic parameters on dual-time-point FDG PET and tumor immune microenvironment marker in non-small cell lung cancer
J Zhou, S Zou, D Kuang, S Cheng, D Li, L Chen, X Zhu - 2019 - Soc Nuclear Med
86 Purpose: Tumor immune microenvironment (TIME) is associated with response to
immunotherapy and outcome of patient with non-small cell lung cancer (NSCLC). Dual-time …
immunotherapy and outcome of patient with non-small cell lung cancer (NSCLC). Dual-time …
New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer
Y Wang, N Zhao, Z Wu, N Pan, X Shen, T Liu… - European journal of …, 2020 - Springer
Background Metabolic information obtained through 18 F-flurodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT) is used to evaluate …
emission tomography/computed tomography (18 F-FDG PET/CT) is used to evaluate …
Correlation of 18F-FDG PET/CT metabolic parameters with the expression of immune biomarkers in the tumour microenvironment in lung adenocarcinoma
LJ Li, JZ Xuan, HN Zheng - Clinical Radiology, 2023 - Elsevier
AIM To explore the association between metabolic parameters evaluated by integrated 2-[18
F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET)/computed …
F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET)/computed …
[HTML][HTML] Different prognostic values of dual-time-point FDG PET/CT imaging features according to treatment modality in patients with non-small cell lung cancer
SJ Jang, JW Lee, JH Lee, IY Jo, SM Lee - Tomography, 2022 - mdpi.com
This study was aimed to investigate whether dual-time-point F-18 fluorodeoxyglucose (FDG)
positron emission tomography (PET)/computed tomography (CT) imaging features had …
positron emission tomography (PET)/computed tomography (CT) imaging features had …
Dynamic 18F-FDG Total Body PET Imaging as a Predictive Marker of Induction Chemo-Immunotherapy Followed by Concurrent Chemoradiotherapy Response in …
H Liu, B Qiu, D Wang, X Zhang, Y Zhou, Q Li… - International Journal of …, 2021 - redjournal.org
Purpose/Objective (s) The purpose of this study was to evaluate the efficacy of dynamic 18F-
FDG total body PET imaging as a predictive maker of induction chemo-immunotherapy …
FDG total body PET imaging as a predictive maker of induction chemo-immunotherapy …
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates …
Purpose Eliciting antitumor T-cell response by targeting the PD-1/PD-L1 axis with
checkpoint inhibitors has emerged as a novel therapeutic strategy in non-small cell lung …
checkpoint inhibitors has emerged as a novel therapeutic strategy in non-small cell lung …
[HTML][HTML] 18F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy
Y Feng, P Wang, Y Chen, W Dai - Nuclear Medicine …, 2023 - journals.lww.com
Objective This study aimed to investigate the relationship between 18 F-fluorodeoxyglucose
PET/computed tomography (18 F-FDG PET/CT) metabolic parameters and clinical benefit …
PET/computed tomography (18 F-FDG PET/CT) metabolic parameters and clinical benefit …
[HTML][HTML] A novel approach using FDG-PET/CT-based radiomics to assess tumor immune phenotypes in patients with non-small cell lung cancer
J Zhou, S Zou, D Kuang, J Yan, J Zhao, X Zhu - Frontiers in Oncology, 2021 - frontiersin.org
Purpose Tumor microenvironment immune types (TMITs) are closely related to the efficacy
of immunotherapy. We aimed to assess the predictive ability of 18F-fluorodeoxyglucose …
of immunotherapy. We aimed to assess the predictive ability of 18F-fluorodeoxyglucose …
Related searches
- fdg pet time point
- fdg pet immune markers
- fdg pet metabolic information
- time point metabolic parameters
- fdg pet tissue expression
- fdg pet upfront surgery
- time point imaging features
- tumour microenvironment immune biomarkers
- time point treatment modality
- metabolic information immune markers
- tissue expression immune markers
- immune biomarkers metabolic parameters
- tumour microenvironment metabolic parameters
- upfront surgery immune markers
- lung adenocarcinoma metabolic parameters
- tissue expression metabolic information